Found 16 matching trials
CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
PHASE1Background:
* The p53 gene normally helps to stop cancer cells from growin...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma
PHASE1The objective of this pilot study is to evaluate the safety, tolerability a...
Location
Hadassah Medical Center
PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
PHASE2CT-011 is an investigational monoclonal antibody. Monoclonal antibodies are...
Location
Beth Israel Deaconess Medical Center
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
PHASE1A Single-arm, Open-label, Multicenter, Phase Ib Clinical Trial to Evaluate ...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
PHASE2Acute myelogenous leukemia (AML) arises from leukemia stem cells that are d...
Location
Beth Israel Deaconess Medical Center
Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
PHASE2The purpose of this research study is to determine the safety of CT-011 alo...
Location
Beth Israel Deaconess Medical Center
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
PHASE2Background:
\- Sipuleucel-T is a new treatment for advanced stage prostate...
Location
Georgia Regents University
Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
PHASE2This clinical trial will be performed in previously untreated patients with...
Location
The Cancer Center of Huntsville, PC
Gemcitabine and CT-011 for Resected Pancreatic Cancer
PHASE2Background:
* In 2009, 49,096 patients were diagnosed with pancreatic canc...
Location
Georgia Regents University
Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma
PHASE2The goal of this clinical research study is to learn if the combination of ...
Location
University of Texas MD Anderson Cancer Center